Mihael H. Polymeropoulos
2017
In 2017, Mihael H. Polymeropoulos earned a total compensation of $3.8M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $502,200 |
|---|---|
| Option Awards | $1,456,406 |
| Salary | $675,000 |
| Stock Awards | $1,131,000 |
| Other | $32,789 |
| Total | $3,797,395 |
Polymeropoulos received $1.5M in option awards, accounting for 38% of the total pay in 2017.
Polymeropoulos also received $502.2K in non-equity incentive plan, $675K in salary, $1.1M in stock awards and $32.8K in other compensation.
Rankings
In 2017, Mihael H. Polymeropoulos' compensation ranked 2,740th out of 14,666 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,740 out of 14,666 | 81st |
Division Manufacturing | 947 out of 5,770 | 84th |
Major group Chemicals And Allied Products | 250 out of 2,074 | 88th |
Industry group Drugs | 190 out of 1,730 | 89th |
Industry Pharmaceutical Preparations | 152 out of 1,329 | 89th |
Source: SEC filing on April 27, 2018.
Polymeropoulos' colleagues
We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2017.
2017
James Kelly
Vanda Pharmaceuticals
Chief Financial Officer
2017
Gian Reverberi
Vanda Pharmaceuticals
Senior Vice President, Chief Commercial Officer
2017
Gunther Birznieks
Vanda Pharmaceuticals
Senior Vice President, Business Development
2017
Richard Gulino
Vanda Pharmaceuticals